Acurx PharmaceuticalsACXP

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1
CEO
Mr. David P. Luci

$32M

Market Cap • 24/04/2024

2017

(há 7 anos)
Fundação

2021

(3 years ago)
IPO

NASDAQ

Listagem
Flag of US

Staten Island

Sede • New York

4

N° de Empregados • 2022

Valuation

Valuation Indicators

Retorno Histórico

ACXPSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

22%

1 semana

16/04/2024

-3%

1 mês

25/03/2024

-37%

1 ano

24/04/2023

10 anos

Histórico